Evusheld

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine. TIME’s Best Inventions of 2022 Cover “These winning innovations exemplify the transformative potential of university research when it aims to solve society’s most urgent problems, and when universities partner with the broader innovation ecosystem to bring... Read More

Two Vanderbilt faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine. TIME’s Best Inventions of 2022 Cover “These winning innovations exemplify the transformative potential of university research when it aims to solve society’s most urgent problems, and when universities partner with the broader innovation ecosystem to bring... Read More

Two Vanderbilt University faculty who conducted translational research have received the distinction of Best Invention of 2022 from TIME magazine.  Read More

The Vanderbilt Vaccine Center will host a campus-wide presentation by Mark Esser, AstraZeneca vice president and head of microbial sciences, about Evusheld, an antibody combination that combats SARS-CoV-2 developed at Vanderbilt University Medical Center. The talk will be on Thursday, Nov. 17, at 10 a.m. in Light Hall, Room 202. Read More

Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19. Read More